Consequently, these findings imply that CD34+ cells may be involved in fibrosis through their differentiation into FABP4+ fibroblasts, which distinguishes them from other cardiac fibroblasts involved in cardiac remodeling in lipid metabolism disorders (hyperlipidemia). Here, FABP4 is linked to hyperlipidemia.